For the nine months ended September 30, 2015, the Company has excluded 899,574 options, 2,997,000 warrants outstanding, and notes convertible into 5,168,639 shares of common stock, because their impact on the loss per share is anti-dilutive.
Dilutive per share amounts are computed using the weighted-average number of common shares outstanding and potentially dilutive securities, using the treasury stock method if their effect would be dilutive.
The following schedule reconciles the denominators of the Companys calculation for basic and diluted net income per share:
Three months ended September 30, 2015
Shares used in basic per share computation 17,756,967
Effect of dilutive common stock options outstanding 571,151
Effect of dilutive conversion options 4,149,408
Shares used in diluted per share computation 22,477,526
|